Human osteosarcoma CD49f−CD133+ cells: impaired in osteogenic fate while gain of tumorigenicity

Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo

(2011) Virginia Tirino et al.   FASEB JOURNAL

Understanding the cancer stem cell

(2010) S Bomken et al.   BRITISH JOURNAL OF CANCER

CD117 and Stro-1 Identify Osteosarcoma Tumor-Initiating Cells Associated with Metastasis and Drug Resistance

(2010) Amit S. Adhikari et al.   CANCER RESEARCH

Integrin Alpha 6 Regulates Glioblastoma Stem Cells

(2010) Justin D. Lathia et al.   Cell Stem Cell

Cancer Stem Cells and Self-renewal

(2010) C. A. O'Brien et al.   CLINICAL CANCER RESEARCH

Prognostic markers in osteosarcoma

(2010) Sameer Bakhshi et al.   Expert Review of Anticancer Therapy

Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity

(2010) Lin Wang et al.   INTERNATIONAL JOURNAL OF CANCER

Therapeutic antibody targeting of individual Notch receptors

(2010) Yan Wu et al.   NATURE

Retinoid-suppressed phosphorylation of RARα mediates the differentiation pathway of osteosarcoma cells

(2010) P Luo et al.   ONCOGENE

Retinoic Acids Potentiate BMP9-Induced Osteogenic Differentiation of Mesenchymal Progenitor Cells

(2010) Wenli Zhang et al.   PLoS One

Expression of an Exogenous Human Oct-4 Promoter Identifies Tumor-Initiating Cells in Osteosarcoma

(2009) P. P. Levings et al.   CANCER RESEARCH

Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis

(2009) E. H. Huang et al.   CANCER RESEARCH

Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors

(2009) Hiroaki Ikushima et al.   Cell Stem Cell

Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer

(2009) E. Charafe-Jauffret et al.   CLINICAL CANCER RESEARCH

Targeting CD133 antigen in cancer

(2009) Gabriella Ferrandina et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment

(2009) Riccardo Di Fiore et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Dysregulated gene expression networks in human acute myelogenous leukemia stem cells

(2009) R. Majeti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD133 as a Marker for Cancer Stem Cells: Progresses and Concerns

(2009) Yaojiong Wu et al.   STEM CELLS AND DEVELOPMENT

The CD34-like protein PODXL and  6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice

(2008) R. H. Lee et al.   BLOOD

Cancer stem cells: markers or biomarkers?

(2008) Wendy A. Woodward et al.   CANCER AND METASTASIS REVIEWS

Osteosarcoma Development and Stem Cell Differentiation

(2008) Ni Tang et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Conditioned media cause increases in select osteogenic and adipogenic differentiation markers in mesenchymal stem cell cultures

(2008) Scott Maxson et al.   Journal of Tissue Engineering and Regenerative Medicine

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas

(2008) Kyeung Min Joo et al.   LABORATORY INVESTIGATION

Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy

(2008) Scott J. Dylla et al.   PLoS One

Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours

(2008) Virginia Tirino et al.   PLoS One

Initiating and Cancer-Propagating Cells in TEL-AML1-Associated Childhood Leukemia

(2008) D. Hong et al.   SCIENCE

Expansion of CD133-Expressing Liver Cancer Stem Cells in Liver-Specific Phosphatase and Tensin Homolog Deleted on Chromosome 10-Deleted Mice

(2008) C. Bart Rountree et al.   STEM CELLS

Therapy for Osteosarcoma

(2008) Alexander J Chou et al.   PEDIATRIC DRUGS